Protein expression profiling predicts graft performance in clinical ex vivo lung perfusion

Annals of Surgery

Volumn 261, Issue 3, 2015, Pages 591-597

  Machuca, Tiago N ^a,b   Cypel, Marcelo ^a,b   Yeung, Jonathan C ^a,b   Bonato, Riccardo ^a,b   Zamel, Ricardo ^b   Chen, Manyin ^a,b   Azad, Sassan ^a   Hsin, Michael K ^a,b   Saito, Tomohito ^b   Guan, Zehong ^b   Waddell, Thomas K ^a,b   Liu, Mingyao ^b   Keshavjee, Shaf ^a,b  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Chemokines; Cytokines; Lung preservation; Lung transplantation; Primary graft dysfunction

Indexed keywords

ALPHA2 INTERFERON; CHEMOKINE; COLONY STIMULATING FACTOR 1; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; GROWTH FACTOR; GROWTH REGULATED ONCOGENE ALPHA; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; STEM CELL FACTOR; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; SIGNAL PEPTIDE;

ADULT; AIRWAY PRESSURE; ARTICLE; ARTIFICIAL VENTILATION; BRAIN DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DONOR SELECTION; EX VIVO LUNG PERFUSION; FEMALE; GRAFT PRESERVATION; HUMAN; INTENSIVE CARE; LUNG GRAFT; LUNG PERFUSION; LUNG TRANSPLANTATION; MALE; ORGAN DONOR; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; CANADA; DONOR; HEART DISEASE; IN VITRO STUDY; LUNG; METABOLISM; MORTALITY; PERFUSION; PROCEDURES; TRANSPLANTATION; VASCULARIZATION;

BIOLOGICAL MARKERS; BRAIN DEATH; CHEMOKINES; CYTOKINES; HEART DISEASES; HUMANS; IN VITRO TECHNIQUES; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG; LUNG TRANSPLANTATION; ONTARIO; PERFUSION; PREDICTIVE VALUE OF TESTS; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS;

EID: 84927029078     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000000974     Document Type: Article

References (31)

1. Israni AK, Zaun DA, Rosendale JD, et al. OPTN/SRTR 2011 Annual Data Report: Deceased organ donation. Am J Transplant. 2013;13: 179-198.
2. Titman A, Rogers CA, Bonser RS, et al. Disease-specific survival benefit of lung transplantation in adults: A national cohort study. Am J Transplant. 2009;9: 1640-1649.
3. CypelM, Yeung JC, Hirayama S, et al. Technique for prolonged normothermic ex vivo lung perfusion. J Heart Lung Transplant. 2008;27: 1319-1325.
4. Cypel M, Yeung JC, Liu M, et al. Normothermic ex vivo lung perfusion in clinical lung transplantation. N Engl J Med. 2011;364: 1431-1440.
5. Yeung JC, Cypel M, Machuca TN, et al. Physiologic assessment of the ex vivo donor lung for transplantation. J Heart Lung Transplant. 2012;31: 1120-1126.
6. Cypel M, Yeung JC, Machuca T, et al. Experience with the first 50 ex vivo lung perfusions in clinical transplantation. J Thorac Cardiovasc Surg. 2012;144: 1200-1206.
7. Allen JG, Lee MT, Weiss ES, et al. Preoperative recipient cytokine levels are associated with early lung allograft dysfunction. Ann Thorac Surg. 2012;93: 1843-1849.
8. Hoffman SA, Wang L, Shah CV, et al. Plasma cytokines and chemokines in primary graft dysfunction post-lung transplantation. Am J Transplant. 2009;9: 389-396.
9. Christie JD, Carby M, Bag R, et al. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: Definition. A consensus statement of the international society for heart and lung transplantation. J Heart Lung Transplant. 2005;24: 1454-1459.
10. De Perrot M, Sekine Y, Fischer S, et al. Interleukin-8 release during early reperfusion predicts graft function in human lung transplantation. Am J Respir Crit Care Med. 2002;165: 211-215.
11. Fisher AJ, Donnelly SC, Hirani N, et al. Elevated levels of interleukin-8 in donor lungs is associated with early graft failure after lung transplantation. Am J Respir Crit Care Med. 2001;163: 259-265.
12. Sekido N, Mukaida N, Harada A, et al. Prevention of lung reperfusion injury in rabbits by amonoclonal antibody against interleukin-8. Nature. 1993;365: 654-657.
13. Kondo T, Novick AC, Toma H, et al. Induction of chemokine gene expression during allogeneic skin graft rejection. Transplantation. 1996;61: 1750-1757.
14. Ahuja N, Andres-Hernando A, Altmann C, et al. Circulating il-6 mediates lung injury via CXCL1 production after acute kidney injury in mice. Am J Physiol Renal Physiol. 2012;303: F864-F872.
15. Batra S, Cai S, Balamayooran G, et al. Intrapulmonary administration of leukotriene B(4) augments neutrophil accumulation and responses in the lung to Klebsiella infection in CXCL1 knockout mice. J Immunol. 2012;188: 3458-3468.
16. Smith RE, Strieter RM, Phan SH, et al. Production and function of murine macrophage inflammatory protein-1 alpha in bleomycin-induced lung injury. J Immunol. 1994;153: 4704-4712.
17. Bless NM, Huber-Lang M, Guo RF, et al. Role of CC chemokines (macrophage inflammatory protein-1 beta, monocyte chemoattractant protein-1, RANTES) in acute lung injury in rats. J Immunol. 2000;164: 2650-2659.
18. Kreisel D, Sugimoto S, Tietjens J, et al. Bcl3 prevents acute inflammatory lung injury in mice by restraining emergency granulopoiesis. J Clin Invest. 2011;121: 265-276.
19. Kreisel D, Sugimoto S, Zhu J, et al. Emergency granulopoiesis promotes neutrophil-dendritic cell encounters that prevent mouse lung allograft acceptance. Blood. 2011;118: 6172-6182.
20. Andres-Hernando A, Dursun B, Altmann C, et al. Cytokine production increases and cytokine clearance decreases in mice with bilateral nephrectomy. Nephrol Dial Transplant. 2012;27: 4339-4347.
21. Sadaria MR, Smith PD, Fullerton DA, et al. Cytokine expression profile in human lungs undergoing normothermic ex-vivo lung perfusion. Ann Thorac Surg. 2011;92: 478-484.
22. Kaneda H, Waddell TK, de PerrotM, et al. Pre-implantation multiple cytokine mRNA expression analysis of donor lung grafts predicts survival after lung transplantation in humans. Am J Transplant. 2006;6: 544-551.
23. Cypel M, Kaneda H, Yeung JC, et al. Increased levels of interleukin-1β and tumor necrosis factor-A in donor lungs rejected for transplantation. J Heart Lung Transplant. 2011;30: 452-459.
24. Naidu BV, Krishnadasan B, Farivar AS, et al. Early activation of the alveolar macrophage is critical to the development of lung ischemia-reperfusion injury. J Thorac Cardiovasc Surg. 2003;126: 200-207.
25. Zhao M, Fernandez LG, Doctor A, et al. Alveolar macrophage activation is a key initiation signal for acute lung ischemia-reperfusion injury. Am J Physiol Lung Cell Mol Physiol. 2006;291: L1018-L1026.
26. KreiselD, Nava RG, Li W, et al. In vivo two-photon imaging revealsmonocytedependent neutrophil extravasation during pulmonary inflammation. Proc Natl Acad Sci U S A. 2010;107: 18073-18078.
27. Salama M, Andrukhova O, Hoda MA, et al. Concomitant endothelin-1 overexpression in lung transplant donors and recipients predicts primary graft dysfunction. Am J Transplant. 2010;10: 628-636.
28. Diamond JM, Lee JC, Kawut SM, et al. Clinical risk factors for primary graft dysfunction after lung transplantation. Am J Respir Crit Care Med 2013;187: 527-534.
29. Cederquist KB, Kelley SO. Nanostructured biomolecular detectors: Pushing performance at the nanoscale. Curr Opin Chem Biol. 2012;16: 415-421.
30. Shah RJ, Bellamy SL, Localio AR, et al. A panel of lung injury biomarkers enhances the definition of primary graft dysfunction (PGD) after lung transplantation. J Heart Lung Transplant 2012;31: 942-949.
31. CypelM, RubachaM, Yeung J, et al. Normothermic ex vivo perfusion prevents lung injury compared to extended cold preservation for transplantation. Am J Transplant. 2009;9: 2262-2269.